Conditions: Gastric Cancer; Gastric Adenocarcinoma; Gastric (Stomach) Cancer; Gastroesophageal Adenocarcinoma; Gastroesophageal Cancer (GC); Gastroesophageal Junction (GEJ) Adenocarcinoma; Gastroesophageal Junction (GEJ) Cancer; Gastrointestinal Cancer Metastatic; Gastrointestinal Adenocarcinoma; Gastrointestinal Cancers; Colorectal (Colon or Rectal) Cancer; Pancreatic Cancer; CDH17-positive Advanced Solid Tumors; Advanced Gastric Cancer
Interventions: Drug: BHB810
Sponsors: BigHat Biosciences, Inc.
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
